PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFN?-driven acquired resistance in preclinical cancer models (2023)

First Author: Wong C
Attributed to:  Regenerative medicine: instrumentation for flow cytometry and cell printing funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-023-41737-1

Publication URI: http://dx.doi.org/10.1038/s41467-023-41737-1

Type: Journal Article/Review

Parent Publication: Nature Communications

Issue: 1